agilon health (AGL) EGM 2026 summary
Event summary combining transcript, slides, and related documents.
EGM 2026 summary
17 Mar, 2026Opening remarks and agenda
The meeting was called to order, with formalities and rules of conduct outlined for participants.
The agenda and procedures were posted online, and the meeting was conducted in accordance with bylaws and Delaware law.
Specific resolutions to be voted on
Proposal one: Amendment to the certificate of incorporation to effect a reverse stock split at a ratio between one-for-five and one-for-25.
Proposal two: Adjournment of the meeting to solicit additional proxies if needed.
Corporate governance
Wendy Shiba of Broadridge Financial Solutions Inc. served as the Independent Inspector of Election.
Quorum was confirmed with a majority of shares present or represented by proxy.
Partial view of Summaries dataset, powered by Quartr API
Latest events from agilon health
- Q2 2026 delivered strong revenue growth and profitability, prompting raised full-year guidance.AGL
Q2 2026 - Cost trends are improving as growth, clinical initiatives, and payer negotiations drive future performance.AGL
2024 Wells Fargo Healthcare Conference - Directors reelected, auditor ratified, and executive pay approved with no shareholder questions.AGL
AGM 2026 - Profitability surged in Q1 2026, prompting raised full-year guidance for key metrics.AGL
Q1 2026 - Tim O'Rourke named CEO and Director with new compensation terms; no changes to voting matters.AGL
Proxy filing - Virtual annual meeting to vote on directors, auditor, and executive pay, with board support.AGL
Proxy filing - Proxy covers director elections, auditor ratification, pay-for-performance, and ESG priorities.AGL
Proxy filing - 2026 guidance targets breakeven EBITDA and $5.5B revenue after cost discipline and transformation.AGL
Q4 2025 - Q3 revenue up 28% to $1.45B, but net loss widened to $118M and guidance was lowered.AGL
Q3 2024